Table 4 The percentage of the biopsy indication for each PGD according to the biopsy period
| Â | 2014 Data (%) | 2019 Data (%) | ||||||
|---|---|---|---|---|---|---|---|---|
AUA | Mixt NS | Nephritic syndrome | NS | AUA | Mixt NS | Nephritic syndrome | NS | |
IgAN | 25.5 | 9.5 | 37.0 | 28.0 | 39.8 | 5.3 | 35.5 | 19.4 |
FSGS | 14.7 | 8.0 | 13.8 | 63.6 | 21.5 | 4.7 | 11.1 | 62.7 |
MN | 5.2 | 3.8 | 2.9 | 88.2 | 13.7 | 3.5 | 1.5 | 81.3 |
MCD | 2.7 | 2.7 | 1.4 | 93.2 | 9.0 | 1.7 | 2.8 | 86.4 |
MPGN | 7.3 | 8.7 | 15.3 | 68.7 | 16.6 | 5.3 | 16.6 | 61.5 |
CGN | 5.1 | 10.2 | 71.2 | 13.6 | 8.0 | 9.3 | 73.5 | 9.3 |